Dr. Marko R. Gudziak, MD

Dr. Gudziak practices at Michigan Institute of Urology in Saint Clair Shores, Michigan.

Dr. Gudziak's NPI, 1871558569, was assigned on April 18, 2006. Dr. Gudziak graduated from New York University School of Medicine in 1987. Dr. Gudziak holds Michigan license 4301063869.

Dr. Gudziak's primary practice is Michigan Institute of Urology, at 20952 12 Mile Rd, Saint Clair Shores, MI 48081 in Macomb County. The practice phone is (586) 771-4820.

Dr. Gudziak's primary practice is Michigan Institute of Urology in Saint Clair Shores, Michigan. Dr. Gudziak is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Michigan Institute of Urology. Dmand AI also links Dr. Gudziak to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gudziak practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gudziak's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gudziak is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gudziak's licenses on file in 4 states: Michigan, Texas, Pennsylvania and New Mexico.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Gudziak treats.

CMS data shows 9,193 Medicare services from Dr. Gudziak across 38 procedure codes in 2024, for 1,128 Medicare patients. Medicare paid $345,826 for them.

CMS counts 1,128 Medicare patients who saw Dr. Gudziak in 2024. The largest group is 75 to 84, with 472 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gudziak's median patient age at 73, with 31% women.

In 2024, Dr. Gudziak wrote 6,032 Medicare Part D claims for 1,305 patients. 93% of them were for generic drugs. CMS names the drug for 5,924 of them, across 34 drugs with 11 or more claims each, at $850,558 in total drug cost. In 2023, CMS named 5,492 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gudziak for performance year 2024, reported as part of a group. Dr. Gudziak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of prostate resection by Dr. Gudziak, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Gudziak. The most frequent topics are Prostatectomy, Prostatic Neoplasms and Urethra. Dr. Gudziak has published most often in J Urol. Dr. Gudziak's most frequent co-authors are Edward L. Gheiler, MD and Leonard G. Gomella, MD.

CMS Open Payments shows 301 general payments to Dr. Gudziak from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Astellas Pharma US Inc paid the most, $764.

Dmand AI lists 2 awards for Dr. Gudziak.

Dr. Gudziak graduated from New York University School of Medicine in 1987. Dr. Gudziak is a member of SLS.

Dr. Gudziak is in network with 17 carriers, including Aetna, Elevance and Health Alliance Plan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.